Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pemetrexed Monochemotherapy in NSCLC
NCT00370292Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Sep 2006
- Primary completion
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in non-small cell lung cancer (NSCLC), sponsored by Eli Lilly and Company. Started Sep 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00370292.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00370292.